Table 3.

ELISPOT result and clinical variablesa

VariableELISPOT (−)(n = 71)ELISPOT (+)(n = 29)P
Recipient age (yr)47 ± 1450 ± 12NS
Male (%)6169NS
Black ethnicity (%)5255NS
DD transplant (%)5669NS (0.25)
Previous transplant (%) 610NS
HLA mismatch3.8 ± 1.73.7 ± 1.3NS
Highly sensitized (%)21 30.03 
HD vintage (mo)35 ± 3153 ± 320.009
Induction therapy (%)1821NS
ATG induction (%) 810NS
MMF therapy (%)3741NS
  • a ATG, antithymocyte globulin; MMF, mycophenolate mofetil.